These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 8585721

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Mode of interaction of G-quartets with the integrase of human immunodeficiency virus type 1.
    Cherepanov P, Esté JA, Rando RF, Ojwang JO, Reekmans G, Steinfeld R, David G, De Clercq E, Debyser Z.
    Mol Pharmacol; 1997 Nov; 52(5):771-80. PubMed ID: 9351967
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cystamine inhibits human immunodeficiency virus-1 replication in cord blood-derived mononuclear phagocytes and lymphocytes.
    Ho WZ, Kaufman D, Song L, Cutillii JR, Douglas SD.
    Blood; 1996 Aug 01; 88(3):928-33. PubMed ID: 8704251
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Diarylsulfones, a new chemical class of nonnucleoside antiviral inhibitors of human immunodeficiency virus type 1 reverse transcriptase.
    McMahon JB, Gulakowski RJ, Weislow OS, Schultz RJ, Narayanan VL, Clanton DJ, Pedemonte R, Wassmundt FW, Buckheit RW, Decker WD.
    Antimicrob Agents Chemother; 1993 Apr 01; 37(4):754-60. PubMed ID: 7684215
    [Abstract] [Full Text] [Related]

  • 9. Effects of nucleotide analogues on human immunodeficiency virus type 1 integrase.
    Mazumder A, Neamati N, Sommadossi JP, Gosselin G, Schinazi RF, Imbach JL, Pommier Y.
    Mol Pharmacol; 1996 Apr 01; 49(4):621-8. PubMed ID: 8609889
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Nuclear localization signal of HIV-1 as a novel target for therapeutic intervention.
    Dubrovsky L, Ulrich P, Nuovo GJ, Manogue KR, Cerami A, Bukrinsky M.
    Mol Med; 1995 Jan 01; 1(2):217-30. PubMed ID: 8529100
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of human immunodeficiency virus type 1 activity in vitro by a new self-stabilized oligonucleotide with guanosine-thymidine quadruplex motifs.
    Suzuki J, Miyano-Kurosaki N, Kuwasaki T, Takeuchi H, Kawai G, Takaku H.
    J Virol; 2002 Mar 01; 76(6):3015-22. PubMed ID: 11861867
    [Abstract] [Full Text] [Related]

  • 16. Ion selective folding of loop domains in a potent anti-HIV oligonucleotide.
    Jing N, Rando RF, Pommier Y, Hogan ME.
    Biochemistry; 1997 Oct 14; 36(41):12498-505. PubMed ID: 9376354
    [Abstract] [Full Text] [Related]

  • 17. Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus type 1 (HIV-1): interference with early and late events in HIV-1 replication.
    Steinkasserer A, Harrison R, Billich A, Hammerschmid F, Werner G, Wolff B, Peichl P, Palfi G, Schnitzel W, Mlynar E.
    J Virol; 1995 Feb 14; 69(2):814-24. PubMed ID: 7815548
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cosalane analogues with enhanced potencies as inhibitors of HIV-1 protease and integrase.
    Cushman M, Golebiewski WM, Pommier Y, Mazumder A, Reymen D, De Clercq E, Graham L, Rice WG.
    J Med Chem; 1995 Feb 03; 38(3):443-52. PubMed ID: 7853337
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.